Streetbeat News

Price Targets

CERE

Goldman Sachs analyst Madhu Kumar maintains a Neutral rating on Cerevel Therapeutics Hldg (NASDAQ:CERE) and lowers the price target from $31 to $30.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:28 am

LLY

TD Cowen analyst Steve Scala maintains an Outperform rating on Eli Lilly (NYSE:LLY) and raises the price target from $430 to $500.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:26 am

ICPT

B of A Securities analyst Geoff Meacham maintains an Underperform rating on Intercept Pharma (NASDAQ:ICPT) and lowers the price target from $17 to $14.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:24 am

STX

B of A Securities analyst Wamsi Mohan maintains a Buy rating on Seagate Tech Hldgs (NASDAQ:STX) and raises the price target from $65 to $71.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:23 am

INTU

Intuit Inc. (NASDAQ: INTU) is expected to report higher Q3 earnings of $8.48 per share, up from $7.65 last year, with revenues of $6.1 billion. The company's shares closed at $454.11 on Monday. Several analysts have recently updated their price targets for the stock.

Portfolio Pulse from Lisa Levin

May 23, 2023 | 11:20 am

STOK

Cantor Fitzgerald analyst Charles Duncan maintains an Overweight rating on Stoke Therapeutics (NASDAQ:STOK) and raises the price target from $20 to $25.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:16 am

CELH

B of A Securities analyst Jonathan Keypour maintains a Buy rating on Celsius Holdings (NASDAQ:CELH) and raises the price target from $125 to $145.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:16 am

RBT

Cantor Fitzgerald analyst Brett Knoblauch maintains an Overweight rating on Rubicon Technologies (NYSE:RBT) but lowers the price target from $2.6 to $1.9.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:10 am

FDS

Stifel analyst Shlomo Rosenbaum maintains a Hold rating on FactSet Research Systems (NYSE:FDS) and raises the price target from $408 to $419.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:09 am

RITM

Raymond James analyst Stephen Laws maintains an Outperform rating on Rithm Capital (NYSE:RITM) but lowers the price target from $12 to $11.5.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:08 am